Stefano Donghi

Dr. Stefano Donghi


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
PDF file
MCMonica Casiraghi
Monica Casiraghi
TPTommaso De Pas
Tommaso De Pas
PMPatrick Maisonneuve
Patrick Maisonneuve
DBDaniela Brambilla
Daniela Brambilla
BCBarbara Ciprandi
Barbara Ciprandi
LSLorenzo Spaggiari
Lorenzo Spaggiari

1 October 2014 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MZMaria Giulia Zampino
Maria Giulia Zampino
PMPatrick Maisonneuve
Patrick Maisonneuve
PRPaola Simona Ravenda
Paola Simona Ravenda
EMElena Magni
Elena Magni
MCMonica Casiraghi
Monica Casiraghi
LSLorenzo Spaggiari
Lorenzo Spaggiari

1 October 2015 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
CCChiara Casadio
Chiara Casadio
JGJuliana Guarize
Juliana Guarize
SDStefano Donghi
Stefano Donghi
CTClementina Di Tonno
Clementina Di Tonno
CFCaterina Fumagalli
Caterina Fumagalli
MBMassimo Barberis
Massimo Barberis
Objectives:. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive procedure that has revolutionized the

1 January 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
Francesco PetrellaFrancesco Petrella
Francesco Petrella
FAFabio Acocella
Fabio Acocella
MBMassimo Barberis
Massimo Barberis
MBMassimo Bellomi
Massimo Bellomi
SBStefano Brizzola
Stefano Brizzola
LSLorenzo Spaggiari
Lorenzo Spaggiari
Large-airway defects and tracheobronchial dehiscence after lung resection present a problem for clinicians because there are few effective methods of treatment.1 Bronchopleural fistula is a pathologic connection between the airway and the pleural space that may develop after lung resection. For many patients with empyema, the presence or absence of a fistula makes the difference between recovery, chronic illness, and death.2,3

4 March 2018 in Canadian Respiratory Journal
Verified
Journal Article
Open access
PDF file
JGJuliana Guarize
Juliana Guarize
MCMonica Casiraghi
Monica Casiraghi
SDStefano Donghi
Stefano Donghi
CDCristina Diotti
Cristina Diotti
NVNicolo Vanoni
Nicolo Vanoni
LSLorenzo Spaggiari
Lorenzo Spaggiari
Background and Objective. EBUS-TBNA has revolutionized the diagnostic approach to thoracic diseases from a surgical to minimally invasive procedure. In non small-cell lung cancer (NCSLC) patients, EBUS-TBNA is able to dictate the consecutive therapy both for early and advanced stages, providing pathological diagnosis, mediastinal staging, and even adequate specimens for molecular analysis. This study reports on the ability of EBUS-TBNA to make different diagnoses and dictates the consecutive therapy in a large cohort of patients presenting different thoracic diseases. Methods. All procedures performed from January 2012 to September 2016 were reviewed. Five groups of patients were created according to the main indications for the procedure. Group 1: lung cancer staging; Group 2: pathological diagnosis in advanced stage lung cancer; Group 3: lymphadenopathy in previous malignancies; Group 4: pulmonary lesions; Group 5: unknown origin lymphadenopathy. In each group, the diagnostic yield of the procedure was analysed. Non malignant diagnosis at EBUS-TBNA was confirmed by a surgical procedure or clinical and radiological follow-up. Results. 1891 patients were included in the analysis. Sensitivity, negative predictive value, and diagnostic accuracy in each group were 90.7%, 79.4%, and 93.1% in Group 1; 98.5%, 50%, and 98.5% in Group 2; 92.4%, 85.1%, and 94.7% in Group 3; 90.9%, 51.0%, and 91.7% in Group 4; and 25%, 83.3%, and 84.2% in Group 5. Overall sensitivity, negative predictive value, and accuracy were 91.7%, 78.5%, and 93.6%, respectively. Conclusions. EBUS-TBNA is the best approach for invasive mediastinal investigation, confirming its strategic role and high accuracy in thoracic oncology.

1 January 2014 in Multimedia Manual of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
Francesco PetrellaFrancesco Petrella
Francesco Petrella
ABA. Borri
A. Borri
MCM. Casiraghi
M. Casiraghi
SCS. Cavaliere
S. Cavaliere
SDStefano Donghi
Stefano Donghi
LSLorenzo Spaggiari
Lorenzo Spaggiari
Palliative airway treatments are essential to improve quality and length of life in lung cancer patients with central airway obstruction. Rigid bronchoscopy has proved to be an excellent tool to provide airway access and control in this cohort of patients. The main indication for rigid bronchoscopy in adult bronchology remains central airway obstruction due to neoplastic or non-neoplastic disease. We routinely use negative pressure ventilation (NPV) under general anaesthesia to prevent intraoperative apnoea and respiratory acidosis. This procedure allows opioid sparing, a shorter recovery time and avoids manually assisted ventilation, thereby reducing the amount of oxygen needed, while maintaining optimal surgical conditions. The major indication for NPV rigid bronchoscopy at our institution has been airway obstruction by neoplastic tracheobronchial tissue, mainly treated by laser-assisted mechanical dissection. When strictly necessary, we use silicone stents for neoplastic or cicatricial strictures, reserving metal stents to cover tracheo-oesophageal fistulae. NPV rigid bronchoscopy is an excellent tool for the endoscopic treatment of locally advanced tumours of the lung, especially when patients have exhausted the conventional therapeutic resources. Laser-assisted mechanical resection and stent placement are the most effective procedures for preserving quality of life in patients with advanced stage cancer.